References

Scully C, Boyle P. The role of the dental team in preventing and diagnosing cancer: 1. Cancer in general. Dent Update. 2005; 32:204-212
Warnakulasuriya S, Dietrich T, Bornstein MM Oral health risks of tobacco use and effects of cessation. Int Dent J. 2010; 60:(7)7-30
London: NICE; 2004
Robertson AG, Robertson C, Soutar DS Treatment of oral cancer: the need for defined protocols and specialist centres. Variations in the treatment of oral cancer. Clin Oncol. 2001; 13:409-415
Cancer Research UK. http://www.cancerresearchuk.org (accessed May 2011)
Kujan O, Glenny A-M, Oliver R, Thakker N, Sloan P. Screening programmes for the early detection and prevention of oral cancer. Cochrane Database of Systematic Reviews. 2006; 19:(3)
Sulaiman F, Huryn JM, Zlotolow IM. Dental extractions in the irradiated head and neck patient: a retrospective analysis of Memorial Sloan-Kettering Cancer Center protocols, criteria and end results. J Oral Maxillofac Surg. 2003; 61:1123-1131
Parliament MB, Scimger RA, Anderson SG Preservation of oral health-related quality of life and salivary flow rates after inverse-planned intensity-modulated radiotherapy (IMRT) for head and neck cancer. Int J Rad Oncol Biol Phys. 2004; 58:663-673
Raber-Durlacher JE, Elad S, Barasch A. Oral mucositis. Oral Oncol. 2010; 46:452-456
Sciubba JJ, Goldenberg D. Oral complications of radiotherapy. Lancet Oncol. 2006; 7:175-183
Keefe DM, Schubert MM, Elting LS Updated clinical practice guidelines for the prevention and treatment of mucositis. Cancer. 2007; 109:(5)820-831
Scottish Intercollegiate Guidelines Network: 90. http://www.sign.ac.uk (accessed 20th April 2010)
Shaw MJ, Kumar NDK, Duggal MLondon: The Dental Faculty of the Royal College of Surgeons of England; 1999
Henriksson R, Fröjd O, Gustafsson H Increase in mast cells and hyaluronic acid correlates to radiation-induced damage and loss of serous acinar cells in salivary glands: the parotid and submandibular glands differ in radiation sensitivity. Br J Cancer. 1994; 69:320-326
Eisbruch A. Reducing xerostomia by IMRT: what may, or may not, be achieved. J Clin Oncol. 2007; 25:4862-4864
Wasserman TH, Brizel DM, Henke M Influence of intravenous amifostine on xerostomia, tumour control, and survival after radiotherapy for head-and-neck cancer: 2-year follow-up of a prospective, randomized, phase III trial. Int J Radiat Oncol Biol Phys. 2005; 63:(4)985-990
Anné PR, Mactay M, Rosenthal DI A Phase II trial of subcutaneous amifostine and radiation therapy in patients with head-and-neck cancer. Int J Radiat Oncol Biol Phys. 2007; 67:445-452
Vissink A, Johannes-Gravenmade E, Panders AK, Vermey A. Treatment of hyposalivation. Ear Nose Throat J. 1988; 67:179-185
Niedermeier W, Matthaeus C, Meyer C Radiation-induced hyposalivation and its treatment with oral pilocarpine. Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 1998; 86:541-549
Zimmerman RP, Mark RJ, Tran LM, Juillard GF. Concomitant pilocarpine during head and neck irradiation is associated with decreased posttreatment xerostomia. Int J Radiat Oncol Biol Phys. 1997; 37:571-575
Hahnel S, Behr M, Handel G, Bürgers R. Saliva substitutes for the treatment of radiation-induced xerostomia – a review. Support Care Cancer. 2009; 17:1331-1343
Porter SR, Fedele S, Habbab KM. Xerostomia in head and neck malignancy. Oral Oncol. 2010; 46:460-463
Ruo Redda MG, Allis S. Radiotherapy-induced taste impairment. Cancer Treatment Rev. 2006; 32:541-547
Maes A, Huygh I, Weltens C De Gustibus: time scale of loss and recovery of tastes caused by radiotherapy. Radiother Oncol. 2002; 63:195-201
Shi H, Masuda M, Umezaki T Irradiation impairment of umami taste in patients with head and neck cancer. Auris Nasus Larynx. 2004; 31:401-406
Fernando IN, Patel T, Billingham L The effect of head and neck irradiation on taste dysfunction: a prospective study. Clin Oncol. 1995; 7:173-178
Chambers MS, Garden AS, Kies MS, Martin JW. Radiation-induced xerostomia in patients with head and neck cancer: pathogenesis, impact on quality of life, and management. Head and Neck. 2004; 26:796-807
Aguiar GP, Jham BC, Magalhāes CS, Sensi LG, Freire AR. A review of the biological and clinical aspects of radiation caries. J Contemp Dent Pract. 2009; 10:(4)83-89
Kielbassa A, Hinkelbein W, Hellwig E, Meyer-Luckel H. Radiation-related damage to dentition. Lancet Oncol. 2006; 7:326-335
Brown LR, Dreizen S, Handler S, Johnson DA. Effect of radiation-induced xerostomia on human oral microflora. J Dent Res. 1975; 54:740-750
Lalla RV, Latortue MC, Hong CH A systematic review of oral fungal infections in patients receiving cancer therapy. Support Care Cancer. 2010; 18:(8)985-992
Katou F, Motegi K, Tagami H, Shirai N, Echigo S, Nagura H. Unique inflammatory features noted in intraorally transferred skin flaps: correlation with Candida albicans infection. Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 1999; 87:(6)676-684
Bensadoun RJ, Riesenbeck D, Lockhart PB, Elting LS, Spijkervet FK, Brennan MT. A systematic review of trismus induced by cancer therapies in head and neck cancer patients. Support Care Cancer. 2010; 18:(8)1033-1038
Garnett MJ, Nohl FS, Barclay SC. Management of patients with reduced oral aperture and mandibular hypomobility (trismus) and implications for operative dentistry. Br Dent J. 2008; 204:125-131
Kent ML, Brennan MT, Noll JL Radiation-induced trismus in head and neck cancer patients. Support Care Cancer. 2008; 16:305-309
Marx RE. Osteoradionecrosis: a new concept of its pathophysiology. J Oral Maxillofac Surg. 1983; 41:(5)283-288
Lyons A, Ghazali N. Osteoradionecrosis of the jaws: current understanding of its pathophysiology and treatment. Br J Oral Maxillofac Surg. 2008; 46:(8)653-660
Delanian S, Lefaix JL. The radiation-induced fibroatrophic process: therapeutic perspective via the antioxidant pathway. Radiother Oncol. 2004; 73:(2)119-131
Madrid C, Abarca M, Bouferrache K. Osteoradionecrosis: an update. Oral Oncology. 2010; 46:(6)471-474
Ben-David MA, Diamante M, Radawski JD Lack of osteoradionecrosis of the mandible after intensity-modulated radiotherapy for head and neck cancer: likely contributions of both dental care and improved dose distributions. Int J Radiat Oncol Biol Phys. 2007; 68:(2)396-402
Reuther T, Schuster T, Mende U, Kubler A. Osteoradionecrosis of the jaw as a side effect of radiotherapy of head and neck tumour patients – a report of a 30 year retrospective review. Int J Oral Maxillofac Surg. 2003; 32:289-295
Delanian S, Depondt J, Lefaix JL. Major healing of refractory mandible osteoradionecrosis after treatment combining pentoxifylline and tocopherol: a phase II trial. Head Neck. 2005; 27:(2)114-123
Annane D, Depondt J, Aubert P Hyperbaric oxygen therapy for radionecrosis of the jaw: a randomized, placebo-controlled, double blind trial from the ORN96 study group. J Clin Oncol. 2004; 22:(24)4893-4900
Bennett MH, Feldmeier J, Hampson N, Smee R, Milross C. Hyperbaric oxygen therapy for late radiation tissue injury. Cochrane Database for Systematic Reviews. 2005; 20:(3)

The role of the general dental practitioner in managing the oral care of head and neck oncology patients

From Volume 39, Issue 10, December 2012 | Pages 694-702

Authors

Suzanne Moore

BDS, BSc, PhD, MFDS RCS(Eng), FDS(Rest Dent) RCS(Eng)

Consultant in Restorative Dentistry, Guy's and St Thomas' Hospitals Foundation Trust, London, UK

Articles by Suzanne Moore

Mary C Burke

AKC, BDS, FDS RCS(Eng)

Consultant in Sedation and Special Care Dentistry, Guy's and St Thomas' Hospitals Foundation Trust, London, UK

Articles by Mary C Burke

Michael R Fenlon

MA, PhD, BDentSc, FDS(RCSEd), MGDS(RCSEd)

Professor of Prosthodontics, Hon Consultant in Restorative Dentistry, KCL Dental Institute at Guy's, King's College and St Thomas' Hospitals, London, UK

Articles by Michael R Fenlon

Avijit Banerjee

BDS, MSc, PhD (Lond), LDS, FDS (Rest Dent), FDSRCS (Eng), FCGDent, FHEA, FICD

Professor of Cariology & Operative Dentistry, Hon Consultant in Restorative Dentistry, King's College London Dental Institute at Guy's Hospital, KCL, King's Health Partners, London, UK

Articles by Avijit Banerjee

Abstract

The general dental practitioner (GDP) plays a critical role in managing head and neck cancer patients. The first and most important role is to offer preventive services, particularly to smokers and to patients who drink alcohol to excess. It is of critical importance that every patient has a systematic examination of oral soft tissues when seen by a GDP. All patients with suspicious lesions should be referred for urgent attention to a specialist centre. Once oral cancer has been diagnosed, GDPs may be presented with patients requiring urgent dentistry, including extractions before commencement of treatment, requiring palliation of symptoms during treatment, or requiring general dentistry after treatment. Radiotherapy provides increased survival but has serious adverse consequences, which may be lifelong, including dry mouth, radiation caries, limitation of mouth opening and high risk of osteonecrosis after extractions. Extraction of teeth in irradiated bone should be referred to specialist centres. Improving survival rates and an ageing population mean that GDPs will see many more survivors of head and neck cancer in the future, with an increased burden of dental care in the longer term and an increased need for monitoring and secondary prevention.

Clinical Relevance: The management of patients with head and neck cancer is complex and involves a multi-disciplinary team, both in the primary treatment but also in the long-term care. This paper reviews the consequences of treatment for head and neck cancer and gives practical advice for GDPs and their team in the long-term care of these patients.

Article

Management of orofacial carcinomas, including prevention, detection and oral care before, during and after treatment of the cancer, should involve the dental team. This paper gives practical advice throughout the care pathway.

An important role of the primary dental care team is the prevention of oral diseases. In this regard, the two most important environmental risk factors in head and neck cancers are tobacco and alcohol.1 In addition, a well-managed smoking cessation programme can be successful when delivered by the dental team.2 The Department of Health has produced guidelines to assist the dental team in aiding their patients to stop smoking (Smokefree and Smiling, Helping Dental Patients to Quit Tobacco, Department of Health publication, 2007) and some of these techniques can be modified to encourage patients to moderate their alcohol intake.

The role of nutritional factors in preventing oral cancers is controversial. Nevertheless, NICE guidance encourages the promotion of a healthy diet.3

Register now to continue reading

Thank you for visiting Dental Update and reading some of our resources. To read more, please register today. You’ll enjoy the following great benefits:

What's included

  • Up to 2 free articles per month
  • New content available